Concepedia

Author

E. Dalmau

Corporació Sanitària Parc TaulíORCID

Also Known As

E Dalmau, E. Dalmau, E. Dalmau Portulas, E. Dalmau Portulàs, E. Dalmau- Pórtulas, Elsa Dalmau, Elsa Dalmau Portulas, Elsa Dalmau Pórtulas, M. Del Mar Gordon Santiago

50

Publications

1.1K

Citations

13

H-Index

23

Concepts

All Affiliations

Corporació Sanitària Parc TaulíUniversitat Autònoma de BarcelonaDeleted InstitutionHospital Universitario 12 De OctubreHospital Clínico San Carlos
ED

About

E. Dalmau is an author at Corporació Sanitària Parc Taulí specializing in medicine, oncology, and biotechnology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

497

2

Engineering

3

3

260

3

Microbiology

3

3

260

4

Biochemistry

2

2

240

5

Gastroenterology

2

2

58

E. Dalmau

×

11

Publications

781

Citations

11

H-Index

YearCitations

Effect of different carbon sources on lipase production by Candida rugosa

E. Dalmau, José Luis González Montesinos, Marina Lotti,

Enzyme and Microbial Technology

2000

216

Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Phase III Trial

Giorgio V. Scagliotti, Maciej Krzakowski, Aleksandra Szczęsna,

Journal of Clinical Oncology

2012

211

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

Thomas Bachelot, Eva Ciruelos, Fabio Puglisi,

Annals of Oncology

2019

111

SEOM clinical guidelines in early stage breast cancer (2018)

Francisco Ayala, Raquel Andrés, José Á. García-Sáenz,

Clinical & Translational Oncology

2018

62

Gastrointestinal stromal tumors

Anna Darnell, E. Dalmau, Carles Pericay,

Abdominal Imaging

2006

45

Analysis of the Pathologic Response to Primary Chemotherapy in Patients with Locally Advanced Breast Cancer Grouped According to Estrogen Receptor, Progesterone Receptor, and HER2 Status

L.A. Fernández-Morales, Miguel Ángel Seguí, Xavier Andreu,

Clinical Breast Cancer

2007

38

Real-world effectiveness of dual HER2 blockade with pertuzumab and trastuzumab for neoadjuvant treatment of HER2-positive early breast cancer (The NEOPETRA Study)

Santiago González-Santiago, Cristina Saura, Eva Ciruelos,

Breast Cancer Research and Treatment

2020

30

Lipase production in continuous culture of <i>Candida rugosa</i>

JL Montesinos, E. Dalmau, C. Casas

Journal of Chemical Technology & Biotechnology

2003

24

Study of the drop size frequencies in a microbial growth system with an aqueous-organic culture medium: lipase production from Candida rugosa

E. Dalmau, Antoni Sánchez, José Luis González Montesinos,

Journal of Biotechnology

1998

20

Gastrointestinal stromal tumors: experience in 49 patients

Eva Artigau Nieto, Alexis Luna Aufroy, E. Dalmau,

Clinical & Translational Oncology

2006

13

Page 1